IMPORTANT UPDATE: Extended Use-by Period for Specific Lots of EpiPen® 0.3mg Adrenaline Auto-Injectors
- 30 September 2019
- News
- Press Releases
Mylan UK have obtained acceptance from the MHRA to extend the use of specific lot numbers of EpiPen® 0.3mg auto-injectors, by 4 months beyond the labelled expiry date. The affected lot numbers are listed in the link below.
Click here to see the affected lot numbers
Important: The extended use only applies to the lots of EpiPen® 0.3mg auto-injectors listed above. Patients can continue to use the EpiPen® 0.3mg auto-injectors of these specified lots safely until the extended use by date as stated above. This extended use does not apply to EpiPen 0.15mg auto-injectors or any lot number of EpiPen® 0.3mg auto-injectors not specified. Patients must continue to adhere to the labelled expiry date on any EpiPen not covered by the lot numbers above.
If you have any questions, you can contact our helpline team at info@anaphylaxis.org.uk or call 01252 542029.
